144 related articles for article (PubMed ID: 17707960)
1. The feasibility of HIV vaccine efficacy trials among Russian injection drug users.
Beyrer C; Baral S; Shaboltas A; Dukhovlinova E; Masharsky A; Verevochkin S; Latkin C; Heimer R; Hoffman I; Kozlov A
Vaccine; 2007 Oct; 25(41):7014-6. PubMed ID: 17707960
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A.
Bobkov AF; Kazennova EV; Selimova LM; Khanina TA; Ryabov GS; Bobkova MR; Sukhanova AL; Kravchenko AV; Ladnaya NN; Weber JN; Pokrovsky VV
J Med Virol; 2004 Oct; 74(2):191-6. PubMed ID: 15332265
[TBL] [Abstract][Full Text] [Related]
3. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
5. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
[TBL] [Abstract][Full Text] [Related]
6. An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks in Moscow and Irkutsk.
Bobkov A; Kazennova E; Khanina T; Bobkova M; Selimova L; Kravchenko A; Pokrovsky V; Weber J
AIDS Res Hum Retroviruses; 2001 Feb; 17(3):257-61. PubMed ID: 11177409
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the number of injection drug users in St. Petersburg, Russia.
Heimer R; White E
Drug Alcohol Depend; 2010 Jun; 109(1-3):79-83. PubMed ID: 20060238
[TBL] [Abstract][Full Text] [Related]
9. An analysis of respondent driven sampling with Injection Drug Users (IDU) in Albania and the Russian Federation.
Stormer A; Tun W; Guli L; Harxhi A; Bodanovskaia Z; Yakovleva A; Rusakova M; Levina O; Bani R; Rjepaj K; Bino S
J Urban Health; 2006 Nov; 83(6 Suppl):i73-82. PubMed ID: 17075727
[TBL] [Abstract][Full Text] [Related]
10. Rapid increase in HIV rates--Orel Oblast, Russian Federation, 1999-2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jul; 52(28):657-60. PubMed ID: 12869903
[TBL] [Abstract][Full Text] [Related]
11. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.
Platt L; Wall M; Rhodes T; Judd A; Hickman M; Johnston LG; Renton A; Bobrova N; Sarang A
J Urban Health; 2006 Nov; 83(6 Suppl):i39-53. PubMed ID: 17096189
[TBL] [Abstract][Full Text] [Related]
12. Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation.
Lowndes CM; Alary M; Platt L
Sex Transm Dis; 2003 Jan; 30(1):46-8. PubMed ID: 12514442
[No Abstract] [Full Text] [Related]
13. Drug use and the risk of HIV infection amongst injection drug users participating in an HIV vaccine trial in Bangkok, 1999-2003.
Martin M; Vanichseni S; Suntharasamai P; Mock PA; van Griensven F; Pitisuttithum P; Tappero JW; Chiamwongpaet S; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Int J Drug Policy; 2010 Jul; 21(4):296-301. PubMed ID: 20079620
[TBL] [Abstract][Full Text] [Related]
14. [HIV infection epidemic in Russian Federation and its features at the present stage].
Goliusova MD
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):97-100. PubMed ID: 22308740
[TBL] [Abstract][Full Text] [Related]
15. Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.
Bobkova MR; Kazennova EV; Selimova LM; Buravtsova EV; Lister S; Prilipov AG; Weber JN; Pokrovsky VV; Bobkov AF
Int J STD AIDS; 2001 Jan; 12(1):34-40. PubMed ID: 11177480
[TBL] [Abstract][Full Text] [Related]
16. Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission.
Heimer R; Barbour R; Shaboltas AV; Hoffman IF; Kozlov AP
AIDS; 2008 Jan; 22(1):123-30. PubMed ID: 18090400
[TBL] [Abstract][Full Text] [Related]
17. [HIV infection in Russia and Commonwealth of Independent States: current situation and prospective].
Onishchenko GG
Zh Mikrobiol Epidemiol Immunobiol; 2003; (3):21-7. PubMed ID: 12886626
[TBL] [Abstract][Full Text] [Related]
18. [Genetic variants of hepatitis C virus in HIV-infected drug users].
Bobkova MR; Samokhvalov EI; Kravchenko AV; Salamov GG; Zverev SIa; Pokrovskiĭ VV; L'vov DK
Vopr Virusol; 2002; 47(3):15-20. PubMed ID: 12173428
[TBL] [Abstract][Full Text] [Related]
19. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
20. Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.
Irwin K; Karchevsky E; Heimer R; Badrieva L
Subst Use Misuse; 2006; 41(6-7):979-99. PubMed ID: 16809182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
